Empiric Therapy for Gastroenteritis
For most patients with acute watery diarrhea (gastroenteritis), empiric antimicrobial therapy is not recommended due to the self-limiting nature of the illness and limited benefit compared to potential risks.
Assessment and Classification
First, determine if the gastroenteritis is:
- Uncomplicated: Watery diarrhea without fever, significant dehydration, or other concerning symptoms
- Complicated: Presence of fever, bloody stools, severe abdominal pain, signs of dehydration or sepsis
Recommended Management Approach
First-Line Treatment (All Patients)
- Fluid replacement therapy is the cornerstone of management:
Antimicrobial Therapy Recommendations
For Most Patients
- Avoid empiric antimicrobial therapy for acute watery diarrhea 1
- Most cases are viral and self-limited
- Average benefit is only 1 day shorter illness duration
- Risk of promoting antimicrobial resistance
Exceptions Where Empiric Antibiotics May Be Considered
- Immunocompromised patients 1, 2
- Ill-appearing young infants (<3 months) 1
- Travelers with severe diarrhea and fever ≥38.5°C 1
- Bloody diarrhea with fever and abdominal pain (suspected shigellosis) 1
- Clinical features of sepsis with suspected enteric fever 1
Specific Antibiotic Recommendations (When Indicated)
For adults when empiric therapy is warranted:
- First choice: Azithromycin 2, 3
- Alternative: Fluoroquinolone (e.g., ciprofloxacin) - but check local resistance patterns 1
For children when empiric therapy is warranted:
Important Cautions
- Avoid antibiotics in suspected STEC infections (E. coli O157:H7) as they may increase risk of hemolytic uremic syndrome 1, 2
- Avoid empiric treatment in persistent watery diarrhea lasting ≥14 days 1
- Do not treat asymptomatic contacts of patients with acute or persistent diarrhea 1
- Discontinue or modify antimicrobial therapy once a specific pathogen is identified 1
Special Considerations
- C. difficile infection: Consider in patients with recent antibiotic exposure or healthcare contact; treat with oral vancomycin or fidaxomicin 2, 5
- Traveler's diarrhea: Fluoroquinolones or azithromycin may be considered for severe cases 1
- Campylobacter infection: Treatment most beneficial if started early in illness course 1
Symptomatic Treatment
- Loperamide: May be used for non-bloody, non-severe diarrhea in adults (4 mg initially, then 2 mg after each loose stool, max 16 mg/day) 2
- Avoid loperamide in children <18 years, bloody diarrhea, or high fever 2
The evidence clearly shows that most cases of gastroenteritis are self-limiting, and the risks of empiric antimicrobial therapy (resistance development, adverse effects, C. difficile infection) typically outweigh the modest benefits of slightly shortened illness duration in uncomplicated cases.